Spectral AI, Inc. announced on October 30, 2024, that the final group of burn center patients in its U.S. Burn Pivotal Study have successfully completed their clinical visits. This milestone represents a crucial step in the validation of the company's AI-driven DeepView System for burn indication.
The U.S. Burn Pivotal Study is one of the largest domestic burn studies ever conducted, designed to validate the DeepView System's algorithm. The completion of patient visits moves the company closer to its planned regulatory submission.
Topline results from this study are anticipated by December 2024. These results will form the foundation of Spectral AI's forthcoming U.S. regulatory submission, aiming to advance the DeepView System towards commercialization.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.